Spots Global Cancer Trial Database for stage iii ovarian epithelial cancer
Every month we try and update this database with for stage iii ovarian epithelial cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00112957 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | rV-NY-ESO-1 vac... rF-NY-ESO-1 vac... | 18 Years - | Ludwig Institute for Cancer Research | |
| Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma | NCT00390234 | Fallopian Tube ... Female Reproduc... Ovarian Carcino... Ovarian Sarcoma Recurrent Ovari... Recurrent Uteri... Stage III Ovari... Stage III Uteri... Stage IV Ovaria... Stage IV Uterin... Uterine Carcino... Uterine Leiomyo... | ziv-aflibercept | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00550784 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim cisplatin cyclophosphamid... melphalan paclitaxel topotecan hydro... TdT-mediated dU... gene expression... immunohistochem... pharmacological... peripheral bloo... | - 60 Years | City of Hope Medical Center | |
| Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer | NCT00337233 | Breast Cancer Fatigue Ovarian Cancer Psychosocial Ef... | yoga therapy | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003385 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin paclitaxel pegylated lipos... | - | GOG Foundation | |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | NCT00522301 | Fallopian Tube ... Ovarian Cancer Primary Periton... | sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | NCT00522301 | Fallopian Tube ... Ovarian Cancer Primary Periton... | sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer | NCT00010179 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer | NCT00093496 | Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | gemcitabine hyd... tanespimycin | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer | NCT00002819 | Ovarian Cancer | carboplatin cyclophosphamid... mitoxantrone hy... paclitaxel autologous bone... peripheral bloo... | - 65 Years | GOG Foundation | |
| Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer | NCT00002568 | Ovarian Cancer | cisplatin paclitaxel conventional su... | - | GOG Foundation | |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00004064 | Fallopian Tube ... Ovarian Cancer Primary Periton... | oregovomab | 18 Years - | National Cancer Institute (NCI) | |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers | NCT00684801 | Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | questionnaire a... quality-of-life... | 18 Years - | Case Comprehensive Cancer Center | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | NCT00003080 | Ovarian Cancer | endocrine-modul... melphalan mitoxantrone hy... tamoxifen citra... thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer | NCT00072410 | Ovarian Cancer | 90Y-hu3S193 111In-hu3S193 | 18 Years - | Ludwig Institute for Cancer Research | |
| Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer | NCT00003072 | Lung Cancer Neurotoxicity Ovarian Cancer | amifostine trih... carboplatin paclitaxel | 18 Years - | University of California, San Francisco | |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer | NCT00004064 | Fallopian Tube ... Ovarian Cancer Primary Periton... | oregovomab | 18 Years - | National Cancer Institute (NCI) | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer | NCT00002671 | Ovarian Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Quality-of-Life Assessment in Patients With Ovarian Cancer | NCT00003772 | Ovarian Cancer | quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Quality-of-Life Assessment in Patients With Ovarian Cancer | NCT00003772 | Ovarian Cancer | quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer | NCT00217529 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pegfilgrastim carboplatin docetaxel erlotinib hydro... | 18 Years - | Fred Hutchinson Cancer Center | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | NCT00006454 | Fallopian Tube ... Ovarian Cancer | carboplatin paclitaxel topotecan hydro... | 18 Years - 120 Years | AGO Study Group | |
| Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy | NCT00003634 | Fallopian Tube ... Ovarian Cancer Primary Periton... | oregovomab | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer | NCT00005051 | Ovarian Cancer | carboplatin cisplatin paclitaxel topotecan hydro... | 18 Years - | NYU Langone Health | |
| Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers | NCT00002538 | Fallopian Tube ... Ovarian Cancer Primary Periton... | laparoscopic su... | 18 Years - | GOG Foundation | |
| S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer | NCT00043082 | Ovarian Cancer Peritoneal Cavi... | carboplatin pegylated lipos... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer | NCT00005807 | Breast Cancer Ovarian Cancer Unspecified Adu... | BMS-247550 | 18 Years - 120 Years | Albert Einstein College of Medicine | |
| Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer | NCT00002671 | Ovarian Cancer | aminocamptothec... | 18 Years - | NYU Langone Health | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer | NCT00003297 | Ovarian Cancer | mitoxantrone hy... thiotepa topotecan hydro... peripheral bloo... | 18 Years - | Georgetown University | |
| S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission | NCT00003120 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | paclitaxel | 18 Years - | SWOG Cancer Research Network | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer | NCT00081276 | Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | triapine cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | NCT00004082 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin docetaxel gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer | NCT00702299 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | cisplatin paclitaxel pemetrexed diso... biologic sample... | 18 Years - | University of Arizona | |
| FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer | NCT00085527 | Ovarian Cancer | depsipeptide | 18 Years - | University of Chicago | |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | NCT00526149 | Breast Cancer Endometrial Can... Head and Neck C... Melanoma (Skin) Ovarian Cancer Sarcoma | BI 2536 high performanc... mass spectromet... pharmacological... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | NCT00118300 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer | capecitabine brachytherapy radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer | NCT00006230 | Ovarian Cancer | rubitecan | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | NCT00522301 | Fallopian Tube ... Ovarian Cancer Primary Periton... | sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | NCT00031954 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | AGO Study Group | |
| Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | NCT01126346 | Advanced Malign... Carcinoma of th... Ovarian Sarcoma Ovarian Stromal... Pseudomyxoma Pe... Recurrent Colon... Recurrent Malig... Recurrent Ovari... Recurrent Ovari... Stage III Colon... Stage III Ovari... Stage III Ovari... Stage IV Colon ... Stage IV Ovaria... Stage IV Ovaria... Unspecified Chi... | HIPEC Orientati... Consultation wi... Questionnaires | - | Wake Forest University Health Sciences | |
| OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer | NCT00382811 | Fallopian Tube ... Peritoneal Neop... Ovarian Cancer | phenoxodiol carboplatin placebo | 18 Years - | MEI Pharma, Inc. | |
| Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00030706 | Ovarian Cancer Peritoneal Cavi... | ixabepilone | 18 Years - 75 Years | Montefiore Medical Center | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00748527 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin decitabine | 18 Years - | National Cancer Institute (NCI) | |
| Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer | NCT00006262 | Ovarian Cancer | becatecarin | 21 Years - | Northwestern University | |
| A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma | NCT00034138 | Ovarian Neoplas... | oregovomab | 18 Years - 65 Years | Unither Pharmaceuticals | |
| Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer | NCT00003322 | Ovarian Cancer Primary Periton... | cisplatin paclitaxel quality-of-life... | - | GOG Foundation | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005026 | Ovarian Cancer Primary Periton... | carboplatin paclitaxel topotecan hydro... | - | GOG Foundation | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | NCT00058435 | Fallopian Tube ... Ovarian Cancer Primary Periton... | abagovomab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum | NCT00003160 | Fallopian Tube ... Ovarian Cancer Primary Periton... | paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer | NCT00003880 | Ovarian Cancer Primary Periton... | recombinant ade... carboplatin paclitaxel | 18 Years - | Merck Sharp & Dohme LLC | |
| Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy | NCT00004166 | Ovarian Cancer Quality of Life | amifostine trih... quality-of-life... | 18 Years - | Northwestern University | |
| Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission | NCT00002977 | Ovarian Cancer | filgrastim melphalan thiotepa peripheral bloo... | 18 Years - 60 Years | Fred Hutchinson Cancer Center | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | NCT00066729 | Fallopian Tube ... Ovarian Cancer Primary Periton... | NY-ESO-1 peptid... | 18 Years - | Ludwig Institute for Cancer Research | |
| Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | NCT00031954 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | AGO Study Group | |
| Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | NCT00003636 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin cisplatin conventional su... neoadjuvant the... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer | NCT00900523 | Ovarian Cancer | protein express... immunohistochem... | 17 Years - | Vanderbilt-Ingram Cancer Center | |
| S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer | NCT00008138 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | carboplatin paclitaxel debulking surge... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer | NCT00702299 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | cisplatin paclitaxel pemetrexed diso... biologic sample... | 18 Years - | University of Arizona | |
| UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | NCT00072267 | Fallopian Tube ... Ovarian Cancer Primary Periton... | 7-hydroxystauro... topotecan hydro... | 18 Years - | University Health Network, Toronto | |
| Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer | NCT00003378 | Ovarian Cancer Primary Periton... | carboplatin gemcitabine hyd... paclitaxel | 18 Years - 80 Years | GOG Foundation | |
| Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | NCT00293293 | Ovarian Cancer Peritoneal Prim... Fallopian Tube ... | healing touch massage therapy hypnosis Standard chemot... | - | Masonic Cancer Center, University of Minnesota | |
| Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy | NCT00466960 | Brenner Tumor Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Peritoneal Cavi... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | sargramostim paclitaxel albu... laboratory biom... immunologic tec... | 18 Years - | University of Washington |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
